Statin therapy in COVID-19 infection.
作者信息
Castiglione Vincenzo, Chiriacò Martina, Emdin Michele, Taddei Stefano, Vergaro Giuseppe
机构信息
Institute of Life Science, Scuola Superiore Sant'Anna, Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):258-259. doi: 10.1093/ehjcvp/pvaa042.
Abstract
摘要
相似文献
1
Statin therapy in COVID-19 infection.新冠病毒感染中的他汀类药物治疗。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):258-259. doi: 10.1093/ehjcvp/pvaa042.
2
Statins in COVID-19: A new ray of hope.新冠疫情中的他汀类药物：一线新希望。
Heart Lung. 2020 Nov-Dec;49(6):887-889. doi: 10.1016/j.hrtlng.2020.07.012. Epub 2020 Aug 11.
3
Statin Treatment of COVID-19.他汀类药物治疗新型冠状病毒肺炎
Am J Cardiol. 2020 Dec 1;136:171-173. doi: 10.1016/j.amjcard.2020.09.050. Epub 2020 Sep 28.
4
Statin therapy in COVID-19 infection: much more than a single pathway.新冠病毒感染中的他汀类药物治疗：远不止单一途径。
Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):410-411. doi: 10.1093/ehjcvp/pvaa055.
5
Use of statins in patients with COVID-19.他汀类药物在新冠肺炎患者中的应用。
QJM. 2020 Aug 1;113(8):604-605. doi: 10.1093/qjmed/hcaa172.
6
Response to: Use of statins in patients with COVID-19.回应：新冠病毒疾病患者使用他汀类药物的情况
QJM. 2020 Aug 1;113(8):606-607. doi: 10.1093/qjmed/hcaa173.
7
Meta-analysis of Effect of Statins in Patients with COVID-19.他汀类药物对新型冠状病毒肺炎患者影响的荟萃分析
Am J Cardiol. 2020 Nov 1;134:153-155. doi: 10.1016/j.amjcard.2020.08.004. Epub 2020 Aug 12.
8
Are certain drugs associated with enhanced mortality in COVID-19?某些药物是否与新冠病毒疾病（COVID-19）死亡率升高有关？
QJM. 2020 Jul 1;113(7):509-510. doi: 10.1093/qjmed/hcaa103.
9
Are statins safe in patients with COVID-19?他汀类药物对新冠肺炎患者安全吗？
J Clin Lipidol. 2020 Jul-Aug;14(4):396-397. doi: 10.1016/j.jacl.2020.06.009. Epub 2020 Jun 22.
10
Statins and other drugs: Facing COVID-19 as a vascular disease.他汀类药物及其他药物：将新冠病毒病视为一种血管疾病来应对
Pharmacol Res. 2020 Sep;159:105033. doi: 10.1016/j.phrs.2020.105033. Epub 2020 Jun 17.
引用本文的文献
1
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury.免疫调节：对抗SARS-CoV-2诱导的心肌损伤的关键。
Front Immunol. 2025 May 14;16:1561946. doi: 10.3389/fimmu.2025.1561946. eCollection 2025.
2
Recent advances in nutritional metabolism studies on SARS-CoV-2 infection.新型冠状病毒感染营养代谢研究的最新进展
Infect Med (Beijing). 2025 Jan 15;4(1):100162. doi: 10.1016/j.imj.2025.100162. eCollection 2025 Mar.
3
The importance of paying attention to the role of lipid-lowering drugs in controlling dengue virus infection.重视降脂药物在控制登革病毒感染中作用的重要性。
Virol J. 2024 Dec 19;21(1):324. doi: 10.1186/s12985-024-02608-3.
4
The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review.长新冠的沉默综合征与科学知识鸿沟：叙事性综述。
Viruses. 2024 Aug 5;16(8):1256. doi: 10.3390/v16081256.
5
Inverse set estimation and inversion of simultaneous confidence intervals.反向集估计与同时置信区间的反演
J R Stat Soc Ser C Appl Stat. 2024 May 31;73(4):1082-1109. doi: 10.1093/jrsssc/qlae027. eCollection 2024 Aug.
6
The critical role of endothelial cell in the toxicity associated with chimeric antigen receptor T cell therapy and intervention strategies.嵌合抗原受体 T 细胞治疗相关毒性的内皮细胞关键作用及干预策略。
Ann Hematol. 2024 Jul;103(7):2197-2206. doi: 10.1007/s00277-024-05640-z. Epub 2024 Feb 8.
7
Atorvastatin Effect on COVID-19 Outcomes: A Propensity Score Matched Study on Hospitalized Patients.阿托伐他汀对新冠病毒病结局的影响：一项针对住院患者的倾向评分匹配研究。
Curr Med Chem. 2024 Jan 21. doi: 10.2174/0109298673264305231025093939.
8
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review.药物重新利用和天然产物对抗新型冠状病毒的有效性：一项综合综述。
Clin Pharmacol. 2024 Jan 4;16:1-25. doi: 10.2147/CPAA.S429064. eCollection 2024.
9
Impact of in-hospital statin use on mortality in COVID-19 patients from a majority African American population.住院期间使用他汀类药物对非裔美国人为主的 COVID-19 患者死亡率的影响。
Heart Lung. 2024 Mar-Apr;64:137-141. doi: 10.1016/j.hrtlng.2023.03.005. Epub 2023 Mar 13.
10
Long-Term Major Adverse Cardiovascular Events in Patients with Moderate and Severe COVID-19: A Focus on Early Statin Use and Previous CVD.中度和重度新冠肺炎患者的长期主要心血管不良事件：重点关注早期他汀类药物使用和既往心血管疾病
J Tehran Heart Cent. 2023 Jul;18(3):183-195. doi: 10.18502/jthc.v18i3.14113.
本文引用的文献
1
Potential Effects of Coronaviruses on the Cardiovascular System: A Review.冠状病毒对心血管系统的潜在影响：综述。
JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286.
2
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection.藏而不露：治疗重症 COVID-19 感染患者的方法。
mBio. 2020 Mar 20;11(2):e00398-20. doi: 10.1128/mBio.00398-20.
3
Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis.羟甲基戊二酰辅酶 A 还原酶抑制剂（他汀类药物）治疗成人脓毒症的系统评价和荟萃分析。
Clin Microbiol Infect. 2019 Mar;25(3):280-289. doi: 10.1016/j.cmi.2018.11.003. Epub 2018 Nov 23.
4
Immune modulatory effects of statins.他汀类药物的免疫调节作用。
Immunology. 2018 May;154(1):69-75. doi: 10.1111/imm.12902. Epub 2018 Feb 20.
5
The role of statins in the setting of HIV infection.他汀类药物在HIV感染情况下的作用。
Curr HIV/AIDS Rep. 2015 Sep;12(3):305-12. doi: 10.1007/s11904-015-0273-9.
6
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.通过TRIF的Toll样受体3信号传导有助于对严重急性呼吸综合征冠状病毒感染产生保护性先天免疫反应。
mBio. 2015 May 26;6(3):e00638-15. doi: 10.1128/mBio.00638-15.
7
Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway.阿托伐他汀减轻大鼠慢性间歇性低氧诱导的心肌重构：TLR-4/MYD88 通路的部分参与。
Biochem Biophys Res Commun. 2014 Mar 28;446(1):292-7. doi: 10.1016/j.bbrc.2014.02.091. Epub 2014 Feb 28.
8
Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival.抑制严重急性呼吸综合征冠状病毒感染小鼠的 NF-κB 介导的炎症可提高生存率。
J Virol. 2014 Jan;88(2):913-24. doi: 10.1128/JVI.02576-13. Epub 2013 Nov 6.
9
Treating influenza with statins and other immunomodulatory agents.用他汀类药物和其他免疫调节剂治疗流感。
Antiviral Res. 2013 Sep;99(3):417-35. doi: 10.1016/j.antiviral.2013.06.018. Epub 2013 Jul 4.
10
Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway.阿托伐他汀通过MyD88依赖途径减弱TLR4介导的NF-κB激活。
Asian Pac J Allergy Immunol. 2009 Mar;27(1):49-57.
Zotero 插件